Studying and deciphering vision-related diseases is complicated by the delicate structure of the eye itself. While biopsies and samples from many other bodily systems are relatively easily obtained by physicians, collecting the vitreous fluid from within the eye is a more challenging task and often fails. The lack of a standardized process to collect and…
Funding from the Taubman Institute has helped a team of researchers develop a new approach to treating aggressive brain tumors. Daniel Wahl, MD, PhD, a radiation oncologist and researcher at Michigan Medicine, says an existing drug used to prevent organ transplant rejection may make radiation therapy more effective for glioblastoma patients by targeting a critical…
The Taubman Institute congratulates Donna M. Martin, MD, PhD, who was appointed chair of the Department of Pediatrics. She also became the Ravitz Foundation Endowed Professor of Pediatrics and Communicable Diseases. Dr. Martin is the Donita B. Sullivan, M.D., Research Professor of Pediatrics and Communicable Diseases, and a professor of pediatrics and human genetics in…
Imaging studies encompass scales of resolution from molecules to patients. Join us Thursday, Aug. 20 at Noon-1 pm via Zoom for this Taubman Technology Talks webinar. Gary Luker, MD, will present several different technologies to meet demands of imaging studies and computational approaches to extract quantitative imaging data from imaging studies. Dr. Luker is a…
Early in the wake of the pandemic as new epidemiological data were emerging, a major concern shared by healthcare workers (HCWs) was the potential to transmit virus without any warning signs. A critical unaddressed issue is whether early detection, especially of infection before obvious symptoms, can prevent “pre-symptomatic transmission” and stop further spread. Sung…
A team of University of Michigan physician-researchers have launched a clinical trial of a drug they believe may address the deadly blood clots that form in some patients with COVID-19. The trial is the first COVID-related investigation to be initiated by Michigan Medicine scientists. The trial is based on the results of a blood inflammation…
A Michigan Medicine physician-investigator and recipient of a Taubman Institute Innovation Projects (TIIP) grant will use samples from COVID-19 patients to study how the virus affects a patient’s immune profile. Daniel Goldstein, MD, last year began a TIIP study that will scrutinize the immune system of organ transplant patients in an effort to refine the…
Srijan Sen, MD, PhD, Associate Professor, Psychiatry, Associate Vice President for Health Sciences, and Frances and Kenneth Eisenberg Professor of Depression and Neurosciences, is one of five mental health care providers and advocates who discuss elevated suicide risk in the most recent issue of BridgeMI.com. In the article, Dr. Sen says, “There is this issue…
The Taubman Institute salutes Scholar Arul Chinnaiyan, MD, PhD, one of four U-M physician-researchers inducted into the National Academy of Sciences class of 2020 on April 27. Dr. Chinnaiyan is the S.P. Hicks Endowed Professor of Pathology, Professor of Urology, Director of the Michigan Center for Translational Pathology in the Medical School, Howard Hughes Medical…
Marschall S. Runge, MD, PhD, Dean, University of Michigan Medical School, Executive Vice President for Medical Affairs, U-M and CEO, Michigan Medicine announced that Kathleen L. Collins, MD, PhD, has been appointed director of the Medical Scientist Training Program (MSTP) in the Medical School. She is a professor of microbiology and immunology and internal medicine…